7Baggers
 published on: 2025-11-14 03:06:14  newser.com Fri, 14 Nov 2025 09:06:14 GMT
 Published on: 2025-11-14 00:40:01  newser.com Fri, 14 Nov 2025 06:40:01 GMT
 Low CRC efficacy bar, few prospects; hello, Cytomx  BioWorld MedTech Wed, 12 Nov 2025 21:20:20 GMT
 cytomx therapeutics stock price target raised to $6.50 at piper sandler by investing.com  Investing.com South Africa Tue, 11 Nov 2025 01:29:15 GMT
 cytomx therapeutics earnings call highlights clinical progress  TipRanks Sun, 09 Nov 2025 00:18:17 GMT
 cytomx therapeutics hits new 52-week high of $4.62, up 157%  Markets Mojo Sat, 08 Nov 2025 23:19:14 GMT
 CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q3 2025 Earnings Call Transcript  Insider Monkey Sat, 08 Nov 2025 14:23:54 GMT
 CytomX Therapeutics Earnings Call Highlights Clinical Progress  TipRanks Sat, 08 Nov 2025 08:00:00 GMT
 cytomx therapeutics (ctmx) reports q3 loss, lags revenue estimates  sharewise.com Sat, 08 Nov 2025 07:20:12 GMT
 cytomx therapeutics hits new 52-week high of $4.62, up 157%  Markets Mojo Fri, 07 Nov 2025 23:15:21 GMT
 CytomX Therapeutics (CTMX) Advances Drug Pipeline with New Leade  GuruFocus Fri, 07 Nov 2025 20:10:48 GMT
 cytomx therapeutics: q3 earnings snapshot  ctinsider.com Fri, 07 Nov 2025 08:43:20 GMT
 published on: 2025-11-07 01:13:13  newser.com Fri, 07 Nov 2025 07:13:13 GMT
 cytomx therapeutics reports q3 2025 financial results  TipRanks Fri, 07 Nov 2025 05:05:23 GMT
 earnings call transcript: cytomx reports q3 2025 revenue drop, stock dips by investing.com  Investing.com South Africa Fri, 07 Nov 2025 04:16:20 GMT
 cytomx therapeutics reports q3 eps (9c), consensus (4c)  TipRanks Fri, 07 Nov 2025 01:29:49 GMT
 cytomx therapeutics: q3 earnings snapshot  San Francisco Chronicle Thu, 06 Nov 2025 23:42:53 GMT
 cytomx (ctmx) q3 revenue falls short, highlights cx-2051 progres  GuruFocus Thu, 06 Nov 2025 22:49:45 GMT
 CytomX Therapeutics Inc Reports Q3 2025 EPS of -$0.09, Revenue a  GuruFocus Thu, 06 Nov 2025 22:02:12 GMT
 published on: 2025-11-06 05:16:00  newser.com Thu, 06 Nov 2025 11:16:00 GMT
 cytomx therapeutics hits new 52-week high at $4.16  Markets Mojo Thu, 06 Nov 2025 08:51:20 GMT
 CytomX Therapeutics Reports Q3 2025 Financial Results  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 cytomx therapeutics hits new 52-week high of $4.18, up 150.92%  Markets Mojo Thu, 06 Nov 2025 07:48:24 GMT
 published on: 2025-11-06 01:30:30  newser.com Thu, 06 Nov 2025 07:30:30 GMT
 cytomx therapeutics (nasdaq:ctmx) shares up 6% - still a buy?  MarketBeat Tue, 04 Nov 2025 20:23:31 GMT
 top biotech stocks riding the rally  Seeking Alpha Tue, 04 Nov 2025 20:15:35 GMT
 cytomx therapeutics hits new 52-week high at $4.16  Markets Mojo Tue, 04 Nov 2025 16:28:56 GMT
 CytomX stock rises after initial data shows CX-801 working as designed  Investing.com Tue, 04 Nov 2025 08:00:00 GMT
 cytomx reports tumor-selective activation in melanoma treatment trial  Investing.com Tue, 04 Nov 2025 08:00:00 GMT
 published on: 2025-11-02 12:38:04  newser.com Sun, 02 Nov 2025 17:38:04 GMT

CytomX Therapeutics, Inc
(NASDAQ:CTMX) 

CTMX stock logo

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (AD...

Full Time Employees: 158
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends